David Wong, Hepatologist in Toronto. UHN/SMH. INTJ
@torontoliver.bsky.social
Translating research to look after patients in the real world rather than a database.
Interests: Hepatitis B, A1AT Deficiency, HIV, Alcohol. #LiverSky
Epic EMR to keep track of it all
Interests: Hepatitis B, A1AT Deficiency, HIV, Alcohol. #LiverSky
Epic EMR to keep track of it all
Toronto Winter Garden Theatre for the Wizard of Oz
December 21, 2024 at 11:56 PM
Toronto Winter Garden Theatre for the Wizard of Oz
Liver Clinic Christmas party
The one where the lab researchers go WILD
The one where the lab researchers go WILD
December 13, 2024 at 8:12 PM
Liver Clinic Christmas party
The one where the lab researchers go WILD
The one where the lab researchers go WILD
Post AASLD debrief on Nov 23, 2024 sponsored by the chineseliversupportgroup.ca
The picture is fake.
The topic is new approaches to HBV therapeutics.
The translators are going to struggle.
#liversky #HBV
The picture is fake.
The topic is new approaches to HBV therapeutics.
The translators are going to struggle.
#liversky #HBV
November 22, 2024 at 1:06 PM
Post AASLD debrief on Nov 23, 2024 sponsored by the chineseliversupportgroup.ca
The picture is fake.
The topic is new approaches to HBV therapeutics.
The translators are going to struggle.
#liversky #HBV
The picture is fake.
The topic is new approaches to HBV therapeutics.
The translators are going to struggle.
#liversky #HBV
The fundamental problem stems from clinicians trying to use immunology terms.
Inactive disease is good immunological control.
Active disease is immune mediated liver injury. Not immune clearance or immune active.
We need to pick a conceptual framework and stick with it. I vote immune framework.
Inactive disease is good immunological control.
Active disease is immune mediated liver injury. Not immune clearance or immune active.
We need to pick a conceptual framework and stick with it. I vote immune framework.
November 19, 2024 at 5:43 PM
The fundamental problem stems from clinicians trying to use immunology terms.
Inactive disease is good immunological control.
Active disease is immune mediated liver injury. Not immune clearance or immune active.
We need to pick a conceptual framework and stick with it. I vote immune framework.
Inactive disease is good immunological control.
Active disease is immune mediated liver injury. Not immune clearance or immune active.
We need to pick a conceptual framework and stick with it. I vote immune framework.
Inpatient consults for abnormal ALT got you down? Poster 4057 at #TLM24 from Don Rockey at MUSC has you covered.
My script for such consults is:
Treat sepsis
Avoid hypotension
Thank you very much
My script for such consults is:
Treat sepsis
Avoid hypotension
Thank you very much
November 18, 2024 at 8:53 PM
Inpatient consults for abnormal ALT got you down? Poster 4057 at #TLM24 from Don Rockey at MUSC has you covered.
My script for such consults is:
Treat sepsis
Avoid hypotension
Thank you very much
My script for such consults is:
Treat sepsis
Avoid hypotension
Thank you very much
Poster 4117 at #TLM24 from Hong Kong. Safe to stop beta blockers in cirrhotics if the cause of cirrhosis is controlled (think HBV) or removed (think HCV, maybe alcohol)
November 18, 2024 at 8:35 PM
Poster 4117 at #TLM24 from Hong Kong. Safe to stop beta blockers in cirrhotics if the cause of cirrhosis is controlled (think HBV) or removed (think HCV, maybe alcohol)
Poster 4103 at #TLM24
Provocative study from BI Deaconess in Boston re cholecystitis in cirrhotics. Argues that percutaneous cholecystectomy tube placement has risk. However did not compare to cholecystectomy in an equally sick cohort.
Provocative study from BI Deaconess in Boston re cholecystitis in cirrhotics. Argues that percutaneous cholecystectomy tube placement has risk. However did not compare to cholecystectomy in an equally sick cohort.
November 18, 2024 at 8:21 PM
Poster 4103 at #TLM24
Provocative study from BI Deaconess in Boston re cholecystitis in cirrhotics. Argues that percutaneous cholecystectomy tube placement has risk. However did not compare to cholecystectomy in an equally sick cohort.
Provocative study from BI Deaconess in Boston re cholecystitis in cirrhotics. Argues that percutaneous cholecystectomy tube placement has risk. However did not compare to cholecystectomy in an equally sick cohort.
Poster 4160 at #TLM24 from Don Rockey's group at MUSC about lactulose. Doctors love it. Patients hate it. Turns out it can cause real harms with hypernatremia.
November 18, 2024 at 8:05 PM
Poster 4160 at #TLM24 from Don Rockey's group at MUSC about lactulose. Doctors love it. Patients hate it. Turns out it can cause real harms with hypernatremia.
Poster 4202 at #TLM24
Ascites pressure causes symptoms and you can make patients feel better with paracentesis.
@ebtapper.bsky.social
Other factors that might contribute to pain include blood or infection in the fluid.
Ascites pressure causes symptoms and you can make patients feel better with paracentesis.
@ebtapper.bsky.social
Other factors that might contribute to pain include blood or infection in the fluid.
November 18, 2024 at 6:45 PM
Poster 4202 at #TLM24
Ascites pressure causes symptoms and you can make patients feel better with paracentesis.
@ebtapper.bsky.social
Other factors that might contribute to pain include blood or infection in the fluid.
Ascites pressure causes symptoms and you can make patients feel better with paracentesis.
@ebtapper.bsky.social
Other factors that might contribute to pain include blood or infection in the fluid.
